Empower Clinics Closes Up 77% On 25M Shares. This Is Why ... And This Is Where It Is Going

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for. Patient visits increased 800% in February. 590% in March and 480% for Q1.

More importantly, it is the only small cap company on the continent (that we know of) that is capable of launching COVID-19 Antibody Testing for individuals and businesses nationwide. Why? Because its simply not enough to be able to get your hands on some test kits. The real challenge is having the infrastructure in place to test people in clinics, via drive though and in the workplace.

It's pretty much a military precision process that few small cap CEO's could handle.

But Empower Clinics CEO, Steven McAuley, is Six Sigma certified under the quality initiative of legendary GE (General Electric) Chairman Jack Welch. We've never seen a Six Sigma certified CEO in the Canadian small cap markets. Never .... which explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into significant growth.

And now he's set his sights on Antibody Testing. He's not just looking, he's already started.

Forget NetFlix Tonight. Watch this.